Letter | Published:

Oncogene ect2 is related to regulators of small GTP-binding proteins

Nature volume 362, pages 462465 (01 April 1993) | Download Citation

Subjects

Abstract

WE have developed an efficient expression cloning system that allows rapid isolation of complementary DNAs able to induce the transformed phenotype1, 2. We searched for molecules expressed in epithelial cells and possessing transforming potential to fibro-blasts, and cloned a cDNA for the normal receptor of a growth factor secreted by NIH/3T3 cells3, 4. Here we report a second novel transforming gene, ect2. The isolated cDNA is activated by amino-terminal truncation of the normal product. The Ect2 protein has sequence similarity within a central core of 255 amino acids with the products of the breakpoint cluster gene, bcr (ref. 5), the yeast cell cycle gene, CDC24 (ref. 6), and the dbl oncogene7. Each of these genes encodes regulatory molecules or effectors for Rho-like small GTP-binding proteins8–10. The baculovirus-expressed Ect2 protein could bind highly specifically to Rho and Rac proteins, whereas the dbl product showed broader binding specificity to Rho family proteins. Thus ect2 is a new member of an expanding family, whose products have transforming properties and interact with Rho-like proteins of the Ras superfamily.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    , , & Gene 83, 137–146 (1989).

  2. 2.

    et al. Proc. natn. Acad. Sci. U.S.A. 88, 5167–5171 (1991).

  3. 3.

    et al. Science 251, 72–75 (1991).

  4. 4.

    et al. Proc. natn. Acad. Sci. U.S.A. 89, 246–250 (1992).

  5. 5.

    & EMBO J. 6, 115–119 (1987).

  6. 6.

    , , & Genetics 74, 267–286 (1973).

  7. 7.

    & Nature 316, 273–275 (1985).

  8. 8.

    et al. Nature 351, 400–402 (1991).

  9. 9.

    & Proc. natn. Acad. Sci. U.S.A. 86, 9976–9980 (1989).

  10. 10.

    , , , & Nature 354, 311–314 (1991).

  11. 11.

    et al. New Biol. 3, 372–379 (1991).

  12. 12.

    , , , & J. Cell Biol. 111, 131–142 (1990).

  13. 13.

    et al. Molec. cell Biol. 10, 5977–5982 (1990).

  14. 14.

    et al. Proc. natn Acad. Sci. U.S.A. 87, 9853–9857 (1990).

  15. 15.

    & Texas Exp Station Bulletin N. 1555 (1987).

  16. 16.

    & Proc. natn. Acad. Sci. U.S.A. 88, 10830–10834 (1991).

  17. 17.

    , , , & Molec. cell. Biol. 10, 1793–1798 (1990).

  18. 18.

    , , & Gene 54, 125–132 (1987).

  19. 19.

    & Cell 67, 459–468 (1991).

  20. 20.

    , , , & Cell 66, 161–171 (1991).

  21. 21.

    , , , & Oncogene 7, 611–618 (1982).

  22. 22.

    , , & Nature 358, 351–354 (1992).

  23. 23.

    et al. Biochem. biophys. Res. Commun. 181, 604–610 (1991).

  24. 24.

    , & Biotechniques 7, 580–589 (1989).

  25. 25.

    , , & Meth. Enzym. 185, 60–89 (1990).

  26. 26.

    , & Molec. cell. Biol 12, 3138–3148 {1992).

  27. 27.

    , , & Nucleic Acids Res. 15, 1869–1869 (1987).

  28. 28.

    & Gene 67, 31–40 (1988).

Download references

Author information

Author notes

    • Timothy P. Fleming

    Present address: Department of Opthalmology and Visual Sciences, Washington University School of Medicine, 660 South Eucid Avenue, St Louis, Missouri 63110, USA.

Affiliations

  1. Laboratory of Cellular and Molecular Biology, National Cancer Institute, Building 37–1E24, 9000 Rockville Pike, Bethesda, Maryland 20892, USA

    • Toru Miki
    • , Cheryl L. Smith
    • , Jason E. Long
    • , Alessandra Eva
    •  & Timothy P. Fleming

Authors

  1. Search for Toru Miki in:

  2. Search for Cheryl L. Smith in:

  3. Search for Jason E. Long in:

  4. Search for Alessandra Eva in:

  5. Search for Timothy P. Fleming in:

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/362462a0

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.